Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Implantable prosthesis
Patent
1994-09-02
1997-08-05
Clarke, Robert A.
Prosthesis (i.e., artificial body members), parts thereof, or ai
Implantable prosthesis
424424, 424425, 623901, A61F 202
Patent
active
056537565
ABSTRACT:
Improved Implant assemblies and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish an improved chamber for holding the implanted cells. The chambers include first and second wall elements and an intermediate sealing element. The first and second wall elements overlie an open area in the sealing member to form a chamber for holding cells for implantation. A sealed region is created between the wall elements and the sealing element body to close the chamber. In one arrangement, the sealed region is created by means of a sonic weld made while the implanted cells are present in the chamber. In another arrangement, the sealed region is created by means of applying an external force to compress the peripheral edges of the wall elements and the sealing element together while the implanted cells are present in the chamber.
REFERENCES:
patent: 3967618 (1976-07-01), Zaffaroni
patent: 3993072 (1976-11-01), Zaffaroni
patent: 4011861 (1977-03-01), Enger
patent: 4266999 (1981-05-01), Baier
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4306318 (1981-12-01), Mano et al.
patent: 4309776 (1982-01-01), Berguer
patent: 4309996 (1982-01-01), Theeuwes
patent: 4352883 (1982-10-01), Lim
patent: 4353888 (1982-10-01), Sefton
patent: 4374669 (1983-02-01), MacGregor
patent: 4378016 (1983-03-01), Loeb
patent: 4391909 (1983-07-01), Lim
patent: 4475916 (1984-10-01), Himmelstein
patent: 4487758 (1984-12-01), Goosen et al.
patent: 4508113 (1985-04-01), Malaney
patent: 4542539 (1985-09-01), Rowe et al.
patent: 4553272 (1985-11-01), Mears
patent: 4576608 (1986-03-01), Homsy
patent: 4601893 (1986-07-01), Cardinal
patent: 4657544 (1987-04-01), Pinchuk
patent: 4664669 (1987-05-01), Ohyabu et al.
patent: 4670286 (1987-06-01), Nyilas et al.
patent: 4673566 (1987-06-01), Goosen et al.
patent: 4686098 (1987-08-01), Kopchick et al.
patent: 4689293 (1987-08-01), Goosen et al.
patent: 4712553 (1987-12-01), MacGregor
patent: 4743252 (1988-05-01), Martin, Jr. et al.
patent: 4795459 (1989-01-01), Jauregui
patent: 4798585 (1989-01-01), Inoue et al.
patent: 4803168 (1989-02-01), Jarvis, Jr.
patent: 4804381 (1989-02-01), Turina et al.
patent: 4806355 (1989-02-01), Goosen et al.
patent: 4816339 (1989-03-01), Tu et al.
patent: 4871366 (1989-10-01), Von Recum et al.
patent: 4877029 (1989-10-01), Valentini et al.
patent: 4878913 (1989-11-01), Aebischer et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4911717 (1990-03-01), Gaskill, III
patent: 4922926 (1990-05-01), Hirschberg et al.
patent: 4936317 (1990-06-01), MacGregor
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4990138 (1991-02-01), Bacich et al.
patent: 5002661 (1991-03-01), Chick et al.
patent: 5024670 (1991-06-01), Smith et al.
patent: 5077215 (1991-12-01), McSuslan et al.
patent: 5182111 (1993-01-01), Aebishcer et al.
patent: 5344454 (1994-09-01), Clarke et al.
David W. Sharpe et al. "Islet Immuno-isolation: The Use of Hybrid Artificial Organs to Prevent Islet Tissue Rejection", World Journal of Surg. 8 pp. 221-229 (1984).
Tissue Reaction to Intraperitoneal Polymer Implants: Species difference and Effects of Corticoid and Doxorubicin, Christineson et al., Journal of Biomedical Materials Research, vol. 23, pp. 705-771, 1989.
Anderson J. "Inflammatory Response to Implants," vol. XXXIV Trans. Am. Soc. Artif. Intern. Organs, 1988 pp. 101-107.
Microtopography and Soft Tissue Response; Campbell et al., Journal of Investigative Surgery, vol. 2, pp. 51-74, 1989.
Macroporous Hydrogel Membranes for a Hybrid Artificial Pancreas. II. Biocompatibility; Klomp et al., Jrnl of Bio-medical Mat. Res., vol. 17, 865-871 (1983).
Abstract of JP 8078845 assigned to Fujisawa Pharm KK and Kyoto Ceramic KK.
Macrophage-derived Growth Factors in Wound Healing: Regulation of Growth Factor Production by the Oxygen Microenvironment; Knighton et al., AM. Rev. Respir. Dis. 1989; 140:1108-1111.
Islet Immuno-Isolation: The Use of Hybrid Artificial Orgns to Prevent Islet Rejection; Scrap et al., World J Surg 8, pp. 221-229 (1984).
The Tissue response to Implants and its Evaluation by Light Microscopy; Von Recum, Soft Tissue Histology pp. 364-378.
Characterization of Biomedical Polymer adherent Macrophages; Interlukin 1 Generation and Scanning Electron Microscopy Studies, Miller et al., Biomaterials, vol. 10, Apr. 1989, pp. 187-205.
Boggs Daniel R.
Brauker James H.
Clarke Robert A.
Hill Ronald S.
Pauley Robin G.
Baxter International Inc.
Clarke Robert A.
LandOfFree
Closed porous chambers for implanting tissue in a host does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Closed porous chambers for implanting tissue in a host, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Closed porous chambers for implanting tissue in a host will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1071610